Drug Type Small molecule drug |
Synonyms CID-2936384, ML 075, ML075 |
Target |
Action antagonists |
Mechanism NPY2R antagonists(Neuropeptide Y receptor type 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H30N2O3 |
InChIKeyUOXMQERPTAMURK-UHFFFAOYSA-N |
CAS Registry1620773-73-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alcoholism | Preclinical | United States | 06 Aug 2010 | |
| Anxiety Disorders | Preclinical | United States | 06 Aug 2010 |





